SOLB Solvay SA

Solvay 2023 Financial Calendar

Solvay 2023 Financial Calendar

Solvay 2023 Financial Calendar



 

Brussels, December 20, 2022, 08:30 CET - Solvay today publishes its 2023 financial calendar and invites the financial community to mark their calendar accordingly. 

Event Date
Full year 2022 earnings  February 23, 2023
First quarter 2023 earnings  May 4, 2023
Ordinary General Shareholders’ Meeting May 9, 2023
First half year 2023 earnings  August 3, 2023
First nine months 2023 earnings  November 3, 2023



Quiet period dates will be provided prior to each earnings’ season.

We invite you to to receive events notifications.



 

Do you want to review our thematic webinars from 2022?

  • (February 2, 2022)
  • (June 15, 2022)
  • (October 4, 2022)



 

More information can be found on

 



EN
20/12/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Solvay SA

Stijn Demeester
  • Stijn Demeester

Solvay/Expectations reset, yield remains attractive/BUY

We update our model and lower our Und. EBITDA estimates by c.12% to reflect Solvay's 2Q25 results and lowered guidance. We reduce our target price to €30 per share from €33.50 yet keep our BUY on the back of Solvay's attractive dividend yield.

Solvay SA: 1 director

A director at Solvay SA bought 1,083 shares at 27.740EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

Wim Hoste
  • Wim Hoste

Solvay Feedback conference call

Below are the key highlights from the conference call. Solvay's 1Q25 uEBITDA dropped 15% to € 230m, in line with the recent profit warning. Solvay reiterated the (recently cut) FY25 underlying EBITDA guidance of € 880-930m (c. -12% at midpoint vs the previous € 1.0-1.05bn range), citing continued soft demand in a context of tariff and geopolitical uncertainty. Solvay had already stated to maintain FCF guidance of c. € 300m (on the back of more prudent capex spending) which however still means th...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch